Focus on FAPI Newsletter – Q3 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2025-12-03T20:09:40+00:004, Sep 2024|Newsletter|

99mTc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction

Cuncun Hua, Xiao-Ying Xi, Yeping Zhang, Ni Suo, Bin Tu, Ye Liu, Xiaoyan Yang, Xiaoyan […]

2025-10-13T13:37:36+00:004, Aug 2024|Publications|

Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel […]

2025-10-15T16:40:45+00:001, Aug 2024|Publications|

SOFIE and GE HealthCare SNMMI Symposium highlights FAP targeting

June 9, 2024 (Toronto, CA) –  SNMMI annual meeting attendees had the opportunity to learn […]

2025-10-15T16:42:10+00:0012, Jun 2024|News|

[68Ga]FAPI-46 Phase 2 clinical development updates

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 Annual SNMMI Meeting – Toronto, Canada
June […]

2025-11-03T16:04:05+00:009, Jun 2024|Presentations|

Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences

NEW YORK (June 4, 2024) – Trilantic North America, a growth-focused middle market private equity […]

2025-10-13T13:31:06+00:004, Jun 2024|News|

Focus on FAPI Newsletter – Q2 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI […]

2025-12-03T20:09:31+00:003, Jun 2024|Newsletter|

The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review

Domenico Albano, Alessio Rizzo, Riemer H J A Slart, Søren Hess, Edel Noriega-Álvarez, Cristina Gamila […]

2025-10-15T16:39:31+00:0031, May 2024|Publications|

Current State of FAP Targeting Radioligands

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
May 30, 2024 Download the Presentation […]

2025-11-04T00:25:14+00:0030, May 2024|Presentations|

Current State of FAP Targeting Radioligands

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
2024 Annual SNMMI Meeting – Toronto, Canada
May […]

2025-11-04T00:50:37+00:0030, May 2024|Presentations|
Go to Top